HSV-2 antibodies do not routinely appear prior to adolescence, and antibody prevalence correlates with prior sexual activity. The primary route of acquisition of HSV-2 infections is via genital-genital sexual contact with an infected partner. HSVCurative is used specifically to treat HSV1 and HSV2 infections and acts as a curative agent against both these strains of herpes.
Currently,
one-fifth of U.S. residents aged 12 years or older are infected with
HSV-2 and one-quarter of U.S. residents aged 30 years or older are
infected with HSV-2. These infection rates and their rise over the
past two decades suggest that genital herpes is nearing epidemic
proportions. HSV-2 antibodies do not routinely appear prior to
adolescence, and antibody prevalence correlates with prior sexual
activity.
The
primary route of acquisition of HSV-2 infections is via
genital-genital sexual contact with an infected partner. Since the
late 1970s, seroprevalence rates for HSV-2 in the United States have
increased by 30%, despite concurrent efforts associated with the
human immunodeficiency virus epidemic to raise awareness of safer sex
practices.
Predictors
of positive HSV-2 serologic status include female sex, black race or
Mexican-American ethnic background, a greater lifetime number of
sexual partners, older age, less formal education, and an income
below the poverty line. For sexually active Americans with a single
lifetime sexual partner, the probability of acquisition of HSV-2 is
10.2%.
This
figure increases to 20.7, 25.9, 30.9, and 46.1% as the number of
lifetime sexual partners increases to 2 to 4, 5 to 9, 10 to 49, and
over 50, respectively. Despite these high seroprevalence rates, only
2 to 3% of adults in the United States report ever having had genital
herpes, and it is this lack of recognition of one's own infection
which contributes to the surreptitious spread of the infection.
Along
with the increased incidence of genital HSV-2 infections over the
past two decades, there has also been a dramatic rise in the
incidence of genital HSV-1 infections. Approximately 10% of cases of
genital herpes in the United States were caused by HSV-1 in the early
1980s. By the mid-1990s, the percentage of primary cases of genital
herpes caused by HSV-1 had doubled to 20%.
In
other parts of the world, HSV-1 accounts for an even larger
percentage of genital herpes cases, with rates in excess of 40%
reported from Singapore, Sweden, England, Norway, and Japan. Genital
HSV-1 infections can result from either genital-genital contact or
oral-genital contact with an infected person who is actively shedding
virus.
Given
the decreased propensity of HSV-1 to reactivate at the genital site,
however, it is oral-genital contact that accounts for most genital
HSV-1 infections. Whites with genital herpes are more likely than
blacks with genital herpes to have infection caused by HSV-1. This
may relate to the younger ages at which orolabial HSV-1 infections
are acquired among minorities, thereby providing a degree of
protection against genital HSV-1 infection in adulthood.
HSVCurative
is used specifically to treat HSV1 and HSV2 infections and acts as a
curative agent against both these strains of herpes. It exhibits a
pronounced anti-herpetic activity against HSV1 and HSV2 and, unlike
other cures for herpes, actually kills these viruses upon exposure
regardless of location on the body.
HSVCurative
is formulated at maximum strength and has produced spectacular
results above other potential herpes cures in eliminating herpes
outbreaks in almost all known cases of use on herpes. It is possibly
the most powerful and effective topical herpes treatment on the
market, providing total clearance of outbreaks time after time.
Topical
application causes herpes outbreaks to dissolve and dry out, with
total clearance commonly experienced in 24 to 36 hours. This herpes
cure gives immediate results and pain relief are certainly
experienced with every application. HSVCurative is therefore proving
to be the unrivaled cure for herpes in the treatment of oral and
genital herpes.
HSVCurative
contains certified organic medicinal plant extracts and antiviral
essential oils which cause cellular death to HSV1 and HSV2 in
scientific studies. HSVCurative has a rather remarkable array of
pharmacological and biochemical properties which inactivate and
destroy the herpes virus for unprecedented results compared to other
cures for herpes.
The
importance of applying certified organic material to outbreaks cannot
be overstated. The herpes cure applied to lesions or open sores is
quickly absorbed into the circulatory system in significant
quantities; hence use of organic material is absolutely essential in
herpes cures. HSVCurative is certified organic and is meant for
medicinal use. To learn more, please go to http://www.bcured.net.
| Additional articles about HSV |
|
|
| About the author |
staff of Nature Power Company, which is a network company dedicated to promoting customers' websites and developing softwares. You can go to the following websites to learn more about our natural organic products. http://www.bcured.net http://www.naturespharma.org |
| Please Rate This Article |
Number of ratings: 0
Rating: 0